Port Huron, Michigan Clinical Trials

A listing of Port Huron, Michigan clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 20 clinical trials
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

This randomized phase II trial studies how well ruxolitinib phosphate, and bosutnib, dasatinib, or nilotinib, work in treating patients with chronic myeloid leukemia. Chronic myeloid leukemia cells produce a protein called BCR-ABL. The BCR-ABL protein helps chronic myeloid leukemia cells to grow and divide. Tyrosine kinase inhibitors, such as bosutinib, …

Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 38 views
  • 11 May, 2021
  • +441 other locations
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

This randomized phase II/III trial studies how well giving maintenance chemotherapy with or without local consolidation therapy works in treating patients with stage IV non-small cell lung cancer. Drugs used in maintenance chemotherapy, such as docetaxel, pemetrexed disodium, erlotinib hydrochloride, and gemcitabine work in different ways to stop the growth …

tumor cells
cancer
pemetrexed
erlotinib
brain metastases
McLaren Cancer Institute-Macomb
 (34.7 away) Contact site
  • 238 views
  • 06 Jun, 2021
  • +193 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

extramammary paget's disease
estimated creatinine clearance
solid tumour
oophorectomy
neuroendocrine carcinoma
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 5957 views
  • 12 Jun, 2021
  • +812 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

chemotherapy regimen
adavosertib
metastatic cancer
solid tumour
bone marrow procedure
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 6087 views
  • 09 Jun, 2021
  • +1015 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

overweight or obesity
body mass index
diabetes
Bluewater Clinical Research
 (3.8 away) Contact site
  • 0 views
  • 10 Jun, 2021
  • +21 other locations
Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

This randomized phase II trial studies how well low-dose ibuprofen in improving cognitive impairment in patients with cancer. Anti-inflammatory agents, such as ibuprofen, may slow the decline of cognitive processes and diseases involving the brain.

cancer
primary cancer
immunostimulants
Bronson Battle Creek
 (145.1 away) Contact site
  • 90 views
  • 10 Feb, 2021
  • +271 other locations
Obinutuzumab With or Without Umbralisib Lenalidomide or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

This phase II trial studies how well obinutuzumab with or without umbralisib, lenalidomide, or combination chemotherapy work in treating patients with grade I-IIIa follicular lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Immunotherapy with obinutuzumab, may induce changes in body's immune system and may interfere …

HIV Infection
avid
prednisone
leukemia
large cell lymphoma
Great Lakes Cancer Management Specialists-Doctors Park
 (15.7 away) Contact site
  • 504 views
  • 06 Jun, 2021
  • +379 other locations
S1613 Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

This randomized phase II trial studies how well trastuzumab and pertuzumab work compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer that has spread from where it started to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as trastuzumab …

metastatic disease
heart failure
hypertension
oophorectomy
potassium
Huron Medical Center PC
 (1.4 away) Contact site
  • 419 views
  • 20 May, 2021
  • +829 other locations
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

This phase II trial studies how well avelumab with or without cetuximab work in treating patients with skin squamous cell cancer that has spread to other places in the body. Immunotherapy with monoclonal antibodies, such as avelumab and cetuximab, may help the body's immune system attack the cancer, and may …

solid tumors
neutrophil count
measurable disease
cetuximab
pd-l1
University of Michigan Comprehensive Cancer Center
 (81.5 away) Contact site
  • 30 views
  • 26 Apr, 2021
  • +390 other locations
Study to Assess the Efficacy Safety and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Study of the efficacy, safety, tolerability, pharmacokinetics (PK), and immunogenicity of Vixarelimab (KPL-716) in subjects with prurigo nodularis.

prurigo
Site 113
 (6.6 away) Contact site
  • 129 views
  • 16 May, 2021
  • +60 other locations